Mills Regan 4

What Happened
Regan Mills, President, Product Test at Teradyne (TER), received equity awards on 2026-02-04: 1,004 restricted stock units (RSUs) and 886 derivative option-type awards, for a total of 1,890 award units. Both awards were granted at $0.00 (standard for grants) and therefore have no immediate cash purchase value. The RSUs and the options will vest over four years beginning February 4, 2027 (see footnotes below).

Key Details

• Transaction date: February 4, 2026; Form 4 filed February 6, 2026 (timely filing).
• Awards: 1,004 RSUs (grant) and 886 derivative option-type awards; grant price shown as $0.00.
• Vesting: RSUs vest in four equal annual installments starting Feb 4, 2027 (F1). Options vest 25% per year over four years beginning Feb 4, 2027 (F2).
• Shares owned after the transaction are not specified in the excerpt provided.
• No 10b5-1 plan, tax withholding, or sale reported in this filing; this is a compensation grant (code A).

Context
RSUs are a promise to deliver shares upon vesting and do not provide immediate tradable shares; option-type awards similarly must vest before being exercisable. Grants like these are typical executive compensation and do not by themselves indicate buying or selling sentiment. They differ from open-market purchases (more directly bullish) and from exercises/sales where shares or cash change hands.